These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26384652)

  • 21. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purinergic signalling and disorders of the central nervous system.
    Burnstock G
    Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purinergic signaling in infectious diseases of the central nervous system.
    Alves VS; Leite-Aguiar R; Silva JPD; Coutinho-Silva R; Savio LEB
    Brain Behav Immun; 2020 Oct; 89():480-490. PubMed ID: 32717399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purinoceptors in the kidney.
    Guan Z; Osmond DA; Inscho EW
    Exp Biol Med (Maywood); 2007 Jun; 232(6):715-26. PubMed ID: 17526763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis.
    Ferrari D; Casciano F; Secchiero P; Reali E
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.
    Baron L; Gombault A; Fanny M; Villeret B; Savigny F; Guillou N; Panek C; Le Bert M; Lagente V; Rassendren F; Riteau N; Couillin I
    Cell Death Dis; 2015 Feb; 6(2):e1629. PubMed ID: 25654762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
    Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
    Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
    Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
    Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purinergic signaling in retinal degeneration and regeneration.
    Reichenbach A; Bringmann A
    Neuropharmacology; 2016 May; 104():194-211. PubMed ID: 25998275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purines and pain mechanisms: recent developments.
    Liu XJ; Salter MW
    Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine.
    Mortensen SP; González-Alonso J; Bune LT; Saltin B; Pilegaard H; Hellsten Y
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1140-8. PubMed ID: 19118095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP stimulates peripheral axons in human, rat and mouse--differential involvement of A(2B) adenosine and P2X purinergic receptors.
    Irnich D; Tracey DJ; Polten J; Burgstahler R; Grafe P
    Neuroscience; 2002; 110(1):123-9. PubMed ID: 11882377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P1-/P2-purinergic receptors on cultured rabbit retinal Müller cells.
    Liu Y; Wakakura M
    Jpn J Ophthalmol; 1998; 42(1):33-40. PubMed ID: 9507363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
    Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
    J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of ecto-purines in inflammation leading to demyelination - new means for therapies against multiple sclerosis].
    Cieślak M; Komoszyński M
    Neurol Neurochir Pol; 2011; 45(5):489-99. PubMed ID: 22127945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular nucleotide and nucleoside signaling in vascular and blood disease.
    Idzko M; Ferrari D; Riegel AK; Eltzschig HK
    Blood; 2014 Aug; 124(7):1029-37. PubMed ID: 25001468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of ectoenzymes on p2 and p1 receptor signaling.
    Kukulski F; Lévesque SA; Sévigny J
    Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.